The role of ultrasound in first-trimester screening after the introduction of NIPT as a service of public health insurance - a consensus statement of the Fetal Medicine Foundation (FMF) Germany

被引：4

作者：

Merz, Eberhard ^{[1
,8
]}

Eiben, Bernd ^{[2
]}

Thode, Christian ^{[3
]}

Hackeloeer, Bernhard-Joachim ^{[4
]}

Faber, Renaldo ^{[5
]}

Tercanli, Sevgi ^{[6
]}

Alkier, Rudolf ^{[7
]}

机构：

[1] Ctr Ultrasound & Prenatal Med, Obstet & Gynecol, Frankfurt, Germany

[2] Inst Klin Genet Nordrhein, Lab Eiben Glaubitz, Essen, Germany

[3] MVZ wagnerstibbe Lab med & Pathol GmbH, Lab med, Gottingen, Germany

[4] Pranatale Gynakol Mammasonog Hamburg, Gynecol & Prenatal Med, Hamburg, Germany

[5] Ctr Prenatal Med, Leipzig, Germany

[6] Univ Spital Basel, Basel, Switzerland

[7] Labor Enders Prof Dr med Gisela Enders & Colleague, Clin Chem, Stuttgart, Germany

[8] Ctr Ultrasound & Prenatal Med, Obstet & Gynecol, Ebersheimstr 5, D-60320 Frankfurt, Germany

来源：

ULTRASCHALL IN DER MEDIZIN | 2023年 / 44卷 / 06期

关键词：

Combined first-trimester screening; contingent screening; cell-free fetal DNA; prenatal ultrasound; chromosome anomalies; CELL-FREE DNA; 1ST TRIMESTER; CHROMOSOMAL-ABNORMALITIES; NUCHAL-TRANSLUCENCY; MATERNAL BLOOD; RISK; TRISOMIES; RECOMMENDATIONS; IMPLEMENTATION; CONTINGENT;

D O I：

10.1055/a-2104-2689

中图分类号：

O42 [声学];

学科分类号：

070206 ; 082403 ;

摘要：

Combined first-trimester screening (FTS) and noninvasive prenatal testing (NIPT) have been proven to be reliable noninvasive procedures to detect the most common chromosomal abnormalities (trisomies 21, 18, 13) in the first trimester. The aim of this paper is to demonstrate the strengths and limitations of these two procedures and to give a consensus statement of the Fetal Medicine Foundation (FMF) Germany on how to use the two techniques in the first trimester after the introduction of NIPT as a service of the statutory health insurance companies in Germany.

引用

页码：600 / 605

页数：6

共 4 条

[1] First-Trimester Screening in Germany After the Introduction of NIPT as a General Health Insurance Benefit
Eiben, Bernd
Glaubitz, Ralf
Winkler, Thomas
Merz, Eberhard
ULTRASCHALL IN DER MEDIZIN, 2023, 44 (03): : 327 - 328
[2] The Fetal Medicine Foundation (FMF) Germany after 20 Years - Quality Assurance of Ultrasound Examinations during First Trimester Screening
Merz, E.
Thode, Ch
Hackeloer, B. J.
Eiben, B.
Faber, R.
Tercanli, S.
Huda, E.
Wellek, S.
ULTRASCHALL IN DER MEDIZIN, 2022, 43 (02): : 115 - 119
[3] First-trimester screening and the new risk-evaluation software from the Fetal Medicine Foundation Germany
Eiben, B.
Thode, C.
Merz, E.
MEDIZINISCHE GENETIK, 2011, 23 (04): : 453 - 456
[4] Trends in nuchal translucency measurement at late first trimester ultrasound, and prenatal diagnostic testing after the introduction of cell-free fetal DNA screening: data from a large health system in New York from 2010-2023
Jackson, Frank I.
Kouba, Insaf
Keller, Nathan A.
Bracero, Luis A.
Vohra, Nidhi
Blitz, Matthew J.
AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2024, 6 (11)

← 1 →